| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.055 | 0.3 |